| Dr Peter Clayton Searl, OD | |
|
2101 Nuuanu Ave Apt 102, Honolulu, HI 96817-1765 | |
| (808) 284-3915 | |
| Not Available |
| Full Name | Dr Peter Clayton Searl |
|---|---|
| Gender | Male |
| Speciality | Optometrist - Sports Vision |
| Location | 2101 Nuuanu Ave Apt 102, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629856216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152WS0006X | Optometrist - Sports Vision | OD-586 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Clayton Searl, OD 2101 Nuuanu Ave Apt 102, Honolulu, HI 96817-1765 Ph: (808) 284-3915 | Dr Peter Clayton Searl, OD 2101 Nuuanu Ave Apt 102, Honolulu, HI 96817-1765 Ph: (808) 284-3915 |
News Archive
Micro Imaging Technology, Inc. has announced that it and Divine Capital Markets, LLC have settled all claims and counterclaims asserted in a lawsuit pending in New York State Supreme Court arising from the issuance of convertible debentures.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has completed the acquisition of ZONARE Medical Systems, Inc., an ultrasound technology leader in the high-end radiology segment pursuant to the terms of the previously announced definitive agreement entered into on June 12, 2013.
Researchers at the Hebrew University of Jerusalem have found a way to maintain the pain-killing qualities of morphine over an extended period of time, thus providing a solution for the problem of having to administer increasing dosages of the drug in order to retain its effectiveness.
› Verified 4 days ago
Courtney E. Muraoka, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 | |
Dr. Jennifer Filiatreau, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2229 N School St, Honolulu, HI 96819 Phone: 808-791-9400 | |
Dr. Calvin Alonzo, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 405 N Kuakini St, Ste 605, Honolulu, HI 96817 Phone: 808-847-7222 | |
Hawaii Vision Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 405 N Kuakini St, #605, Honolulu, HI 96817 Phone: 808-225-7622 | |
Pearl Harbor Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4725 Bougainville Dr, Honolulu, HI 96818 Phone: 808-422-2210 Fax: 808-422-2262 | |
Kalihi Family Eyecare, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1620 N School St Ste 143, Honolulu, HI 96817 Phone: 808-845-2221 | |
Dirk Vernon Fujii, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1441 Kapiolani Blvd, Suite 805, Honolulu, HI 96814 Phone: 808-946-6136 Fax: 808-943-6236 |